Nausea · people with CKD
It is very uncertain whether summary of findings: Sevelamer changes nausea compared with placebo/usual care (very low certainty).
1 finding from 1 review
Vomiting · people with CKD
It is very uncertain whether summary of findings: Sevelamer changes vomiting compared with placebo/usual care (very low certainty).
1 finding from 1 review
Constipation · people with CKD
Summary of findings: Sevelamer may leads to higher constipation compared with placebo/usual care (low certainty).
1 finding from 1 review
Serum phosphate level · people with CKD
1 finding from 1 review
Coronary artery calcification score · people with CKD
1 finding from 1 review
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Lanthanum changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Systolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Blood pressure target achievement · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
Organisational interventions probably leads to higher blood pressure target achievement compared with usual care (moderate certainty).
1 finding from 1 review
Medication adherence (continuous) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
LDL‐cholesterol · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
HbA1c (%) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Body‐mass index (BMI) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Diastolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Blood pressure target achievement · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
Educational or behavioural interventions for patients showed no clear difference in blood pressure target achievement compared with usual care (moderate certainty).
1 finding from 1 review
Medication adherence (continuous) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
LDL‐cholesterol · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
HbA1c (%) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Body‐mass index (BMI) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Systolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Diastolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review